{"id":"W4414572355","doi":"10.1016/j.ebiom.2025.105929","title":"Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial","year":2025,"lang":"en","type":"article","venue":"EBioMedicine","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"NIHR Clinical Research Network North West London; Radboud Universitair Medisch Centrum; ViiV Healthcare","keywords":"Pharmacokinetics; Clinical trial; MEDLINE; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00510688,0.001929852,0.002815511,0.0003315949,0.0006148668,0.00130337,0.000929737,0.00138106,0.004639212],"category_scores_gemma":[0.004035547,0.0008603766,0.003218825,0.0004043963,0.001643855,0.001085678,0.0009171858,0.002835575,0.0008774812],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001623593,"about_ca_system_score_gemma":0.003161452,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002890795,"about_ca_topic_score_gemma":0.006170851,"domain_scores_codex":[0.9972948,0.001549934,0.0001679303,0.0004064058,0.0002359578,0.0003447858],"domain_scores_gemma":[0.9970716,0.0006651122,0.0006978204,0.0004438523,0.0002775037,0.0008440504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9504229,0.0205674,0.003911957,0.0008567627,0.001928464,0.0001563328,0.0003640637,0.0005809267,0.009069297,0.0002511736,0.001441441,0.01044932],"study_design_scores_gemma":[0.7701567,0.2124679,0.01118593,0.00006183839,0.001326966,0.0002387706,0.0001476842,0.000480646,0.001442646,0.0002481926,0.00220188,0.00004101262],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818796,0.00135562,0.0006081692,0.000225176,0.0001100836,0.01203751,0.002392869,0.00005374475,0.001337311],"genre_scores_gemma":[0.9772778,0.0009851365,0.003716579,0.000576192,0.0002410909,0.01167465,0.00330012,0.00003681844,0.002191664],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00510688,"threshold_uncertainty_score":0.02700812,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01538462642912101,"score_gpt":0.314817308919119,"score_spread":0.299432682489998,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}